Press release
Octreotide Market Research Reveals Path To $3.26 Billion By 2030
Octreotide
Projected Growth and Size of the Octreotide Market Through 2030
The octreotide market size has been steadily increasing and is projected to continue this trend. It is expected to grow from $2.56 billion in 2025 to $2.69 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.0%. This historical growth has been fueled by successful acromegaly treatments, a rise in diagnosed neuroendocrine tumors, the availability of depot formulations, expansion of endocrine specialty care, and greater adoption of hospital-based hormone therapies. Looking ahead, the market is anticipated to reach $3.26 billion by 2030, with a CAGR of 4.9%. Growth during this period is expected to be driven by increasing demand for long-acting injectables, rising prevalence of endocrine disorders, expanding oncology uses, enhanced hospital infusion capacities, and innovations in sustained-release formulations. Key trends shaping the market include broader use in hormonal disorder management, increasing preference for long-acting injectables, growth in neuroendocrine tumor treatments, higher demand for hospital-administered therapies, and a stronger emphasis on symptom control for chronic conditions.
Download a free sample of the octreotide market report:
https://thebusinessresearchcompany.com/sample_request?id=89579898&type=smp&name=Octreotide%20Market%20Report%202026&utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR
Top Companies Leading the Octreotide Market
The octreotide landscape is shaped by several prominent companies, including Novartis International AG, Viatris Inc., Teva Pharmaceutical Industries Ltd., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd., Ipsen S.A., Aurobindo Pharma Limited, Dr. Reddy's Laboratories Ltd., Hikma Pharmaceuticals PLC, Bachem Holding AG, Chemi S.p.A., LGM Pharma LLC, Hainan Shuangcheng Pharmaceuticals Co. Ltd., USV Private Limited, ChemWerth Inc., Shanghai Soho-Yiming Pharmaceuticals Co. Ltd., Neiss Labs Private Limited, Samarth Life Sciences Private Limited, TAPI Technology & API Services, and BCN Peptides S.A. A noteworthy event occurred in April 2023 when Italy-based Chiesi Farmaceutici S.p.A. acquired Ireland-based Amryt Pharma Plc for an undisclosed sum. This strategic move broadens Chiesi's rare disease portfolio and strengthens its ability to deliver innovative treatments, enhancing patient access to breakthrough therapies in rare and complex disease areas. Amryt Pharma specializes in octreotide-based treatments for rare and orphan diseases.
Key Market Trends Supporting Octreotide's Growth
Leading firms in the octreotide sector are prioritizing the development of innovative product formats like injectable suspensions to boost patient compliance and convenience. Injectable suspensions provide rapid absorption by delivering medication directly into the bloodstream, bypassing the digestive system, which leads to a faster onset of action. For instance, in October 2024, Israel-based Teva Pharmaceuticals introduced a generic version of Sandostatin LAR Depot (octreotide acetate injectable suspension), aimed at delivering quick therapeutic effects through injection. Octreotide itself is a synthetic analog of the natural hormone somatostatin, mainly used to treat acromegaly, carcinoid syndrome, and VIP-secreting tumors. This injectable method simplifies adherence to treatment regimes by accelerating drug action compared to traditional oral tablets.
View the full octreotide market report:
https://www.thebusinessresearchcompany.com/report/octreotide-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Oct_PR
Comprehensive Segmentation Within the Octreotide Market
This report categorizes the octreotide market into several key segments:
1) By Type: Octreotide Acetate, Octreotide, Octreotide Chloride, Octreotide Hydrochloride, Indium In-111 Octreotide
2) By Form: Injection, Powder, Microspheres
3) By Indications: Diarrhea, Acromegaly, Other Indications
4) By Distribution Channel: Hospital Pharmacy, Online Pharmacy, Retail Pharmacy
5) By End-user: Pharmaceutical, Clinical Research
Further subsegment details include:
- Octreotide Acetate: Injectable Formulation, Depot Injectable Formulation
- Octreotide: Injectable Formulation, Oral Formulation
- Octreotide Chloride: Injectable Formulation, Lyophilized Powder
- Octreotide Hydrochloride: Injectable Formulation, Lyophilized Powder
- Indium In-111 Octreotide: Diagnostic Radiopharmaceutical Formulation, Therapeutic Radiopharmaceutical Formulation
This extensive classification provides a clear understanding of the market's diverse product types, forms, applications, and distribution channels, supporting a nuanced analysis of growth opportunities across the octreotide sector.
Our latest 2026 market reports provide expanded strategic and visual intelligence with market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, together with updated graphics and tables.
Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
With over 30,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Octreotide Market Research Reveals Path To $3.26 Billion By 2030 here
News-ID: 4672823 • Views: …
More Releases from The Business Research Company
Oncogene Inhibitor Market Outlook Highlights Strategic Opportunities Across The …
The oncogene inhibitor market has witnessed significant growth over recent years, driven by advancements in cancer treatment and rising awareness of targeted therapies. As research and development continue to push boundaries, this sector is poised for strong expansion in the coming years. Let's explore the current market size, key factors fueling growth, prominent players, emerging trends, and detailed segment insights shaping the global oncogene inhibitor landscape.
Oncogene Inhibitor Market Size and…
Nucleotides Supplements Market Outlook Signals Expansion To $4.74 Billion Throug …
An increasing awareness surrounding cellular nutrition and advancements in nutraceutical manufacturing are driving significant interest in the nucleotides supplements market. As consumer demand grows in both human and animal nutrition sectors, the market is poised for substantial growth. Let's explore the current market value, key players, emerging trends, and major segments shaping the nucleotides supplements industry.
Market Size and Growth Trajectory of the Nucleotides Supplements Market
The nucleotides supplements market has…
Non-Therapeutic Biomolecules Market Insights Highlight Segment Expansion And Mar …
The non-therapeutic biomolecules sector has witnessed remarkable expansion in recent years, driven by technological advances and growing applications across various fields. As the market continues to diversify and innovate, exciting prospects lie ahead for stakeholders and researchers alike. Below, we explore the current market size, growth drivers, leading companies, trending innovations, and detailed segmentation guiding this dynamic industry.
Non-Therapeutic Biomolecules Market Size and Growth Forecast Through 2030
The market for non-therapeutic…
Non-Alcoholic Steatohepatitis Treatment Market Report Provides Insights Into Mar …
The treatment landscape for non-alcoholic steatohepatitis (NASH) is evolving rapidly, reflecting a growing focus on addressing this serious liver condition. With rising awareness, medical advancements, and increasing investment, the market for NASH therapies is set to expand significantly in the coming years. Here's a detailed overview of the market's size, driving factors, key players, and emerging trends.
Non-Alcoholic Steatohepatitis Treatment Market Size and Growth Forecast
The market value for non-alcoholic steatohepatitis…
More Releases for Octreotide
Octreotide Acetate Market is Rising in Upcoming Years | 2024-2031
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Octreotide Acetate Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The impact of manufacturers on the market is significant across various industries, influencing supply chains, consumer choices, and economic growth. Manufacturers are key players in…
Octreotide Acetate Market Size and Forecast
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- The global Octreotide Acetate Market is expected to record a CAGR of XX.X% from 2024 to 2031 In 2024, the market size is projected to reach a valuation of USD XX.X Billion. By 2031 the valuation is anticipated to reach USD XX.X Billion.
The octreotide acetate market is witnessing steady growth due to its critical role in the treatment of various medical conditions such as acromegaly, neuroendocrine tumors,…
Octreotide Market to 2030: Ongoing research and development efforts aimed at imp …
Octreotide is a medication used in the treatment of various medical conditions such as acromegaly, carcinoid syndrome, and diarrhea. It is a synthetic analogue of the naturally occurring hormone somatostatin and acts by suppressing the release of certain hormones and neurotransmitters in the body. The octreotide market is a growing market, with increasing demand for the drug in the treatment of various medical conditions. Major pharmaceutical companies are involved in…
Global Octreotide Market 2019 - Novartis, Sun Pharmaceutical, Chengdu Tiantaisha …
This new report by Eon Market Research, titled “Global Octreotide Market 2019 Research Report, 2015 – 2025” offers a comprehensive analysis of Octreotide industry at a global as well as regional and country level. Key facts analyzed in this report include the Octreotide market size by players, regions, product types and end industries, history data 2014-2018 and forecast data 2019-2025. This report primarily focuses on the study of the competitive…
Octreotide Market: Competitive Dynamics & Global Outlook 2023
New report published by Market Research Report Store (MRRS) which offers insights on the global Octreotide market.
Octreotide is an octapeptide that mimics natural somatostatin pharmacologically，it is a more potent inhibitor of growth hormone, glucagon, and insulin than the natural hormone. Usually in the form of a salt of acetic acid.
The production of Octreotide mainly focuses on Europe, China and India. The Europe occupies the largest share and it about reach…
Octreotide Market - Size, Share, Outlook, and Opportunity Analysis, 2018-2026
Octreotide is an octapeptide that resembles natural somatostatin pharmacologically. Octreotide acetate is widely used in treatment of some types of cancers, diarrhea, and tumors such as carcinoid, pancreatic islet cell tumors, and vasoactive intestinal peptide secreting tumors. Octreotide acetate is also used to treat acromegaly when the body produces excess of growth hormone, which causes enlarged feet, hands, face, and head.
Access Table of Content (TOC) Of the Report @ https://www.coherentmarketinsights.com/ongoing-insight/toc/1836
Octreotide…
